433 - 444 of 7742 results
0.25 CME CREDIT

In this podcast, infectious disease specialist Dr. Woc-Colburn answers your questions from the past few weeks with a focus on COVID-19 transmission and what precautions to follow as we return to the “new normal”. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/3/2020 and they are subject to change as new information is published.


1 CME CREDIT

In the fifth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss strategies for adapting clinical practice to virtual platforms and explain how telehealth has changed as a result of the COVID-19 pandemic. They will review requirements for providing various types of telehealth visits (audio only vs. audio plus video) and share practical advice on getting reimbursed for these encounters, including review of common billing codes. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 4/28/2020 and they are subject to change as new information is published.


0.25 CME CREDIT

This session will discuss the latest evidence on concussion occurrence among high school athletes and review return-to play-guidelines and laws. It will also provide a nuanced and realistic discussion of concussion prevention.


Coffee with Chopra: Episode 3
0.5 CME CREDIT

Join Dr. Sanjiv Chopra, MD, in this installment of Coffee with Chopra, as he interviews his guest, Dr. Peng Fan, MD, about advances in rheumatology. In this session, the duo will discuss topics including: ANA testing, the revolution of biologics in rheumatology, stem cell treatment, the microbiome, and joint replacements.


0.25 CME CREDIT

Skilled nursing facilities experienced some of the first clusters of COVID-19 outbreaks in the United States. In this episode, geriatrician Lee Lindquist will discuss how the characteristics of COVID-19 and the policies surrounding testing contributed to the spread of the virus in skilled nursing facilities. She will outline practical policies that skilled nursing facilities can implement to protect their patients and staff, and stop the spread of infection within their facilities. Lastly, she will discuss opportunities for policy changes moving forward to prevent future outbreaks in these vulnerable settings. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/18/2020 and they are subject to change as new information is published.


1 CME CREDIT

In the second episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the risks to healthcare workers associated with COVID-19. They will review current data on systems-based solutions to reduce transmission risk, the importance of personal protective equipment (PPE), and when to discontinue precautions in patients with resolved COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/09/2020, and they are subject to change as new information is published.


1 CME CREDIT

In the third episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss important information for clinicians to relay to their patients regarding COVID-19. They will review current recommendations around how patients should be instructed to protect themselves and high-risk family members, how to monitor symptoms when sick, and how to determine when it’s appropriate to end self-isolation. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/16/2020 and they are subject to change as new information is published.


FAQ for the Pharmacotherapy of Alcohol and Opioid Use Disorders

In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.Guest: Petros Levounis, MD, MA

In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.